Recommendation of the surgical option for treatment of encapsulating peritoneal sclerosis

Peritoneal Dialysis International

Volumn 28, Issue SUPP. 3, 2008, Pages

  Kawanishi, Hideki ^a   Moriishi, Misaki ^a   Ide, Kentaro ^a   Dohi, Kiyohiko ^a  

^a TSUCHIYA GENERAL HOSPITAL   (Japan)

Author keywords

Encapsulating peritoneal sclerosis; EPS; Surgical options

Indexed keywords

ANTIINFECTIVE AGENT; STEROID; TAMOXIFEN;

ABDOMINAL SCINTISCANNING; ABDOMINAL SURGERY; ADHESIOLYSIS; CATHETER REMOVAL; CONFERENCE PAPER; DRUG EFFICACY; ENCAPSULATING PERITONEAL SCLEROSIS; ENTEROLYSIS; HUMAN; INTESTINE OBSTRUCTION; LONG TERM CARE; OUTCOME ASSESSMENT; PERITONEAL DIALYSIS; PERITONEAL DISEASE; PERITONEUM LAVAGE; PERITONITIS; POSTOPERATIVE COMPLICATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; SEPSIS; SURGICAL TECHNIQUE; TREATMENT DURATION; TREATMENT RESPONSE; TREATMENT WITHDRAWAL;

DIGESTIVE SYSTEM SURGICAL PROCEDURES; GLUCOCORTICOIDS; HUMANS; PERITONEAL DIALYSIS; PERITONEAL DISEASES; PERITONEAL LAVAGE; PERITONEUM; RECURRENCE; SCLEROSIS; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TAMOXIFEN;

EID: 48749126804     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (24)

1. Nomoto Y, Kawaguchi Y, Kubo H, Hirano H, Sakai S, Kurokawa K. Sclerosing encapsulating peritonitis in patients undergoing continuous ambulatory peritoneal dialysis: a report of the Japanese Sclerosing Encapsulating Peritonitis Study Group. Am J Kidney Dis 1996; 28:420-7.
2. Rigby RJ, Hawley CM. Sclerosing peritonitis: the experience in Australia. Nephrol Dial Transplant 1998;13:154-9.
3. Kawaguchi Y, Saito A, Kawanishi H, Nakayama M, Miyazaki M, Nakamoto H, et al. Recommendations on the management of encapsulating peritoneal sclerosis in Japan, 2005: diagnosis, predictive markers, treatment, and preventive measures. Perit Dial Int 2005; 25(Suppl 4):S83-95.
4. Kawanishi H, Kawaguchi Y. Prevalence and therapeutic outcome of sclerosing encapsulating peritonitis (EPS) - a multicenter study in Japan (Japanese). Jin To Toseki 2000; 49(Suppl):225-8.
5. Kawanishi H, Watanabe H, Moriishi M, Tsuchiya S. Successful surgical management of encapsulating peritoneal sclerosis. Perit Dial Int 2005; 25(Suppl 4):S39-47
6. Kawanishi H, Kawaguchi Y, Fukui H, Hara S, Imada A, Kubo H, et al. Encapsulating peritoneal sclerosis in Japan: a prospective, controlled, multicenter study. Am J Kidney Dis 2004; 44:729-37.
7. Dobbie JW. Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis. Perit Dial Int. 1992; 12:14-27.
8. De Vriese AS, Tilton RG, Stephan CC, Lameire NH. Vascular endothelial growth factor is essential for hyperglycemia-induced structural and functional alterations of the peritoneal membrane. J Am Soc Nephrol 2001; 12:1734-41.
9. Kawanishi H, Harada Y, Noriyuki T Kawai T, Takahashi S, Moriishi M, et al. Treatment options for encapsulating peritoneal sderosis based on progressive stage. Adv Perit Dial 2001; 17:200-4.
10. Kawanishi H, Fujimori A, Tsuchida K, Takamoto Y, Tomo T, Minakuchi J, et al. Markersin peritoneal effluent for withdrawal from peritoneal dialysis: multicenter prospective study in Japan. Adv Perit Dial 2005; 21:21-4.
11. Yamamoto R, Nakayama M, Hasegawa T, Numata M, Yamamoto H, Yokoyama K, et al. High-transport membrane is a risk factor for encapsulating peritoneal sclerosis developing after long-term continuous ambulatory peritoneal dialysis treatment. Adv Perit Dial 2002; 18:131-4.
12. Williams JD, Topley N, Craig KJ, Mackenzie RK, Pischetsrieder M, Lage C, et al. on behalf of the Euro Balance Trial Group. The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (Balance) on the peritoneal membrane. Kidney Int 2004; 66:408-18.
13. Piraino B, Bailie GR, Bernardini J, Boeschoten E, Gupta A, Holmes C, et al. on behalf of the ISPD Ad Hoc Advisory Committee. Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int 2005; 25:107-31.
14. Nakayama M, Yamamoto H, Ikeda M, Hasegawa T, Kato N, Takahashi H, et al. Risk factors and preventive measures for encapsulating peritoneal sclerosis - Jikei experience 2002. Adv Perit Dial 2002; 18:144-8.
15. Moriishi M, Kawanishi H, Kawai T, Takahashi S, Hirai T, Shishida M, et al. Preservation of peritoneal catheter for prevention of encapsulating peritoneal sclerosis. Adv Perit Dial 2002; 18:149-53.
16. Allaria PM, Giangrande A, Gandini E, Pisoni IB. Continuous ambulatory peritoneal dialysis and sclerosing encapsulating peritonitis: tamoxifen as a new therapeutic agent? J Nephrol 1999; 12:395-7.
17. Eltoum MA, Wright S, Atchley J, Mason JC. Four consecutive cases of peritoneal dialysis-related encapsulating peritoneal sclerosis treated successfully with tamoxifen. Perit Dial Int 2006; 26:203-6.
18. del Peso G, Baio MA, Gil F, Aguilera A, Ros S, Costero O, et al. Clinical experience with tamoxifen in peritoneal fibrosing syndromes. Adv Perit Dial 2003; 19:32-5.
19. Junor BJ, McMillan MA. Immunosuppression in sclerosing peritonitis. Adv Perit Dial 1993; 9:187-9.
20. Mori Y, Tatsuo S, Sutoh H, Toriyama T, Kawahara H, Hotta N. A case of a dialysis patients with sclerosing peritonitis successfully treated with corticosteroid therapy alone. Am J Kidney Dis 1997; 30:275-8.
21. Kawanishi H, Harada Y, Sakikubo E, Moriishi M, Nagai T, Tsuchiya S. Surgical treatment for sclerosing encapsulating peritonitis. Adv Perit Dial 2000; 16:252-6.
22. Kawanishi H, Moriishi M, Tsuchiya S. Experience of 100 surgical cases of encapsulating peritoneal sclerosis: investigation of recurrent cases after surgery. Adv Perit Dial 2006; 22:60-4.
23. Noble TB. Plication of small intestine as prophylaxis against adhesions. Am J Surg 1937; 35:41-4.
24. Seabrook DB, Wilson ND. Prevention and treatment of intestinal obstruction by use of the Noble procedure. Am J Surg 1954; 88:186-93